The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication
Abstract
BACKGROUND: Proton-pump inhibitor (PPI)-based triple therapy is the recommended first-line treatment for Helicobacter pylori infection. A consensus on treatment duration is lacking. PURPOSE: To summarize the benefits and harms of different durations of PPI-based triple therapy. DATA SOURCES: PubMed, EMBASE, the Cochrane Library, and proceedings of major meetings through May 2007. STUDY SELECTION: English-language reports of randomized, controlled trials that compared duration (7, 10, or 14 days) of triple therapy and in which adequate testing confirmed the initial H. pylori infection and its eradication. DATA EXTRACTION: Two authors independently extracted data on study design, treatment, number of patients enrolled and number of patients with successful eradication, disease at enrollment, testing, adverse effects, year of publication, publication format, and country. DATA SYNTHESIS: Of 21 included studies, 11 compared 7-day therapy with 10-day therapy, and 13 compared 7-day therapy with 14-day therapy. Meta-analysis yielded relative risks (RRs) for eradication of 1.05 (95% CI, 1.01 to 1.10) for 7-day compared with 10-day amoxicillin-containing triple therapy (10 studies) and 1.07 (CI, 1.02 to 1.12) for 7-day compared with 14-day therapy (11 studies). Meta-analysis of the 3 studies that compared 7-day with 14-day metronidazole-containing therapy yielded an RR of 1.08 (CI, 0.96 to 1.22). The 7-day versus 10-day comparisons yielded RRs of 1.03 (CI, 0.97 to 1.10) for peptic ulcer disease and 1.10 (CI, 1.02 to 1.20) for nonulcer dyspepsia. For the 7-day versus 14-day comparisons, the RRs were 1.04 (CI, 0.99 to 1.09) and 1.03 (CI, 0.88 to 1.20), respectively. The RRs for frequency of adverse events were 0.98 (CI, 0.85 to 1.14) and 1.08 (CI, 0.84 to 1.40) for 7-day therapy compared with 10- and 14-day therapy, respectively. Diarrhea and taste disturbance were the most frequently reported adverse events (5%). LIMITATIONS: Subgroup analyses were limited by the few studies evaluating different drug regimens and disease at enrollment. Seventeen of the included studies had poor methodological quality or inadequate reporting. CONCLUSION: Available data suggest that extending triple therapy beyond 7 days is unlikely to be a clinically useful strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529786 · Cited by 4,332 · cited 1×
“We used the coefficient to measure the strength of agreement between the 2 investigators (18).”
MethodMoher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
Research works printed but not linked: 41
- 10.1056/NEJMra020542 · DOI · Paper page
- 10.1046/j.1365-2036.2000.00744.x · DOI · Paper page
- 10.1155/2003/714124 · DOI
- 10.1136/gut.2006.101634 · DOI · Paper page
- 10.1046/j.1365-2036.2002.01169.x · DOI · Paper page
- 10.1111/j.1365-2036.2004.02029.x · DOI
- 10.1016/j.dld.2003.12.015 · doi:10.1016/j.dld.2003.12.015
- 10.1111/j.1572-0241.2005.00178.x · doi:10.1111/j.1572-0241.2005.00178.x
- 10.1111/j.1572-0241.2005.50019.x · doi:10.1111/j.1572-0241.2005.50019.x
- 10.1155/2006/258768 · doi:10.1155/2006/258768
- 10.1111/j.1523-5378.2007.00468.x · DOI
- 10.1111/j.1523-5378.2006.00459.x · doi:10.1111/j.1523-5378.2006.00459.x
- 10.1136/gut.2006.102269 · doi:10.1136/gut.2006.102269
- 10.7326/0003-4819-134-5-200103060-00008 · DOI · Paper page
- 10.1046/j.1365-2036.2003.01746.x · DOI
- 10.1093/aje/kwh090 · DOI · Paper page
- Mantel N, 1959, J Natl Cancer Inst, 22, 719
- Grade AJ, 1996, Gastroenterology, 110, A121, 10.1053/gast.1996.v110.pm8536848 · DOI
- Monès J, 1997, Gastroenterology, 112, A224
- Katicic M, 1996, Gut, 39, A144
- Kiyota K, 1999, J Gastroenterol, 34, 76
- 10.4038/cmj.v49i4.1921 · DOI
- 10.1016/S0016-5085(98)81029-9 · doi:10.1016/s0016-5085(98)81029-9
- 10.3748/wjg.v10.i5.668 · DOI
- Lamouliatte H, 1998, Gut, 43, A80
- 10.1046/j.1523-5378.2000.00012.x · doi:10.1046/j.1523-5378.2000.00012.x
- 10.1046/j.1523-5378.2000.00006.x · DOI
- 10.1111/j.1440-1746.1998.01557.x · doi:10.1111/j.1440-1746.1998.01557.x
- Ching CK, 1998, Hong Kong Med J, 4, 7
- 10.1046/j.1365-2036.1996.111282000.x · doi:10.1046/j.1365-2036.1996.111282000.x
- 10.1046/j.1365-2036.2000.00800.x · doi:10.1046/j.1365-2036.2000.00800.x
- 10.1111/j.1572-0241.2001.03519.x · doi:10.1111/j.1572-0241.2001.03519.x
- 10.1111/j.1523-5378.1996.tb00012.x · doi:10.1111/j.1523-5378.1996.tb00012.x
- 10.1046/j.1365-2036.1998.00382.x · doi:10.1046/j.1365-2036.1998.00382.x
- 10.1016/S0016-5085(00)84092-5 · doi:10.1016/s0016-5085(00)84092-5
- Palmas F, 2002, Panminerva Med, 44, 145
- Gisbert JP, 2001, Hepatogastroenterology, 48, 1383
- 10.1080/003655201300191978 · doi:10.1080/003655201300191978
- 10.1136/bmj.38414.515938.8F · DOI · Paper page
- 10.1016/S0140-6736(96)90538-3 · DOI · Paper page
- 10.1016/S1286-4579(03)00112-6 · DOI · Paper page
Cited by
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Metadata
- Authors
- Fuccio, L., Minardi, M. E., Zagari, R. M., Grilli, D., Magrini, N., & Bazzoli, F.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-10-16
- Volume
- 147
- Issue
- 8
- Pages
- 553-562
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2060752995
- Cited by
- 248
- References
- 6
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication. https://app.cochat.ai/papers/10.7326/0003-4819-147-8-200710160-00008
- The paper
- Fuccio, L., Minardi, M. E., Zagari, R. M., Grilli, D., Magrini, N., & Bazzoli, F. (2007). Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-147-8-200710160-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.